Duration of Treatment Effect of IncobotulinumtoxinA in Upper Limb Spasticity (P4.036)

Conclusions:These results demonstrate variability in the duration of treatment effect, which supports the use of flexible and individualized dosing intervals for the treatment of ULPSS. The duration of treatment effect was ≥14 weeks after most treatments; however, a considerable proportion of patients experienced effects lasting up to 20 weeks.Study Supported by: Merz Pharmacueticals GmbHDisclosure: Dr. Rubin has received personal compensation for activities with Allergan and Merz as a speaker and advisory board member. Dr. Kanovsky has received research support from Merz. Dr. Elovic has received personal compensation from Allergan, Inc., and Solstice Neurosciences. Dr. Munin has received personal compensation for activities with Merz. Dr. Althaus has received personal compensation from Merz Neuroscience as an employee. Dr. Hanschmann has received personal compensation for activities with Merz Pharma as an employee. Dr. Pulte has received personal compensation for activities with Merz Pharmaceuticals as an employee. Dr. Marciniak has received personal compensation for activities with Merz. Dr. Marciniak has received research support from Allergan, Ipsen, and Merz.

Source: Neurology - April 17, 2017 Category: Neurology Authors: Rubin, B., Kanovsky, P., Elovic, E., Munin, M., Althaus, M., Hanschmann, A., Pulte, I., Marciniak, C. Tags: Neuro-rehabilitation: Motor Recovery and Spasticity Treatment Source Type: research